Trv Gp Ii
Latest statistics and disclosures from Trv Gp Ii's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Jounce Therapeutics, and represent 100.00% of Trv Gp Ii's stock portfolio.
- Reduced shares in these 2 stocks: Jounce Therapeutics, Allena Pharmaceuticals.
- Sold out of its position in Allena Pharmaceuticals.
- Trv Gp Ii was a net seller of stock by $-2.3M.
- Trv Gp Ii has $1.3M in assets under management (AUM), dropping by -70.98%.
- Central Index Key (CIK): 0001614073
Tip: Access up to 7 years of quarterly data
Positions held by Trv Gp Ii consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Trv Gp Ii
Trv Gp Ii holds 1 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Jounce Therapeutics | 100.0 | $1.3M | -57% | 573k | 2.34 |
|
Past Filings by Trv Gp Ii
SEC 13F filings are viewable for Trv Gp Ii going back to 2017
- Trv Gp Ii 2022 Q3 filed Nov. 3, 2022
- Trv Gp Ii 2022 Q2 filed Aug. 12, 2022
- Trv Gp Ii 2022 Q1 filed May 10, 2022
- Trv Gp Ii 2021 Q4 filed Feb. 14, 2022
- Trv Gp Ii 2021 Q3 filed Nov. 5, 2021
- Trv Gp Ii 2021 Q2 filed Aug. 11, 2021
- Trv Gp Ii 2021 Q1 filed May 12, 2021
- Trv Gp Ii 2020 Q4 filed Feb. 16, 2021
- Trv Gp Ii 2020 Q3 filed Nov. 6, 2020
- Trv Gp Ii 2020 Q2 filed Aug. 10, 2020
- Trv Gp Ii 2020 Q1 filed May 11, 2020
- Trv Gp Ii 2019 Q4 filed Feb. 5, 2020
- Trv Gp Ii 2019 Q3 filed Nov. 4, 2019
- Trv Gp Ii 2019 Q2 filed Aug. 6, 2019
- Trv Gp Ii 2019 Q1 filed May 3, 2019
- Trv Gp Ii 2018 Q4 filed Jan. 28, 2019